Login
← Go Back
Glaxosmithkline Pharmaceuticals
GLAXO · Pharma > Pharmaceuticals & Drugs · Chairman: R S Karnad · MD: S Venkatesh · Listing date: Oct. 25, 1994 · Employees: 4283 · Mumbai · http://india-pharma.gsk.com
Stock Price vs Company Growth
1d
1.0%
1w
2.3%
1m
12.8%
3m
34.6%
6m
20.4%
1y
6.4%
5y
17.2%
10y
9.3%
all
11.1%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 2,926 1.0%
2,088
3,121
Company Overview
Sales
3,955 Cr
Growth: 3.8%
Profit after Tax
1,048 Cr
Growth: 3.2%
Large Cap
49,568 Cr
P/E: 47.0x
Industry P/E: 34.2x
Fundamentals
Sales (Cr) ₹ 3,955
Growth 3.8%
EBITDA 34.2%
P/S 12.7x
Dividend 1.3%
P/E 47.0x
Book Value ₹ 148
PEG Ratio 12.2x
ROE 42.4%
P/B 20.0x
Shareholding Pattern
Institutions
Qualified Institutional Buyer
5.33 %
Life Insurance Corporation Of India
4.78 %
Aditya Birla Sun Life Trustee Private Limited A/C Aditya Birla Sun Life Nifty Midcap 150 Index Fund
3.47 %
General Insurance Corporation Of India
1.42 %
Promoters
Glaxo Group Limited
35.99 %
Glaxosmithkline Pte Limited
28.1 %
Eskaylab Limited
6.94 %
Burroughs Wellcome International Limited
3.97 %
Others
Iepf
0.23 %
Increase    Decrease    No change
Company Profile Detailed
The company is engaged in research, manufacture and making available a broad range of medicines and vaccines that benefit people. The company’s pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in anti-infectives and dermatology. Its R&D approach focuses on science related to the immune system, use of genetics and advanced technologies.
Belongs to (32 Indices) view more
Investors (37)
rajarshi...
lic.of.i...
qualifie...
Followers (11)
surendra...
sandeep1...
nihal